What Does BB/TM Stand For?

The Literal Answer: What BB/TM Stands For

BB/TM stands for Blood Banking/Transfusion Medicine, and in the context of physician credentialing it refers specifically to Certification in Pathology: Blood Banking/Transfusion Medicine, an initial subspecialty certification administered by the American Board of Pathology (ABPath). It is not a job title or a generic industry term - it is a formal, examination-based credential that a pathologist earns after completing an accredited fellowship and passing a dedicated one-day exam.

If you have landed here searching "what does BB/TM stand for," you are most likely evaluating whether to pursue this subspecialty certification, preparing to register for the exam, or trying to understand what the letters mean on a colleague's or physician's credentials list. This article answers all three angles, and where relevant, links out to deeper resources such as our BB/TM Requirements 2026: Eligibility, Prerequisites & How to Qualify guide and our BB/TM Exam Domains 2026: Complete Guide to All 15 Content Areas breakdown.

Which BB/TM Is This? Avoiding a Common Mix-Up

The three letters "BB/TM" appear in more than one professional context, and it is easy to confuse them. This site, and this article, deal exclusively with the ABPath-administered physician subspecialty certification described above. This is a different credential from laboratory specialist certifications that also touch blood banking, such as SBB(ASCP), which is aimed at medical laboratory scientists rather than pathologists. If you are researching the medical technologist route instead of the physician pathway, the requirements, exam structure, and governing organization will be different from everything discussed here.

Throughout this article, "BB/TM" refers only to the ABPath physician credential. For a fuller definitional walkthrough, see What Is BB/TM? and BB/TM Meaning.

Who Issues the BB/TM Credential

The American Board of Pathology (ABPath) is the certifying body. BB/TM is one of ABPath's initial subspecialty certifications, meaning it builds on top of a primary certification rather than standing alone as a first credential. To even sit for the exam, a candidate must already hold AP/CP or CP primary certification from ABPath, or primary certification from another American Board of Medical Specialties (ABMS) member board.

This layered structure matters when you interpret the acronym: BB/TM is not an entry-level credential. It signals that a physician has already completed general pathology certification and then pursued additional, focused fellowship training and testing in transfusion medicine specifically.

Inside the Exam: Format, Fee, and Testing Window

Understanding what BB/TM stands for is easier once you see what the exam actually looks like. The 2026 examination fee is $2,100, which includes a $200 nonrefundable administrative fee. Testing takes place at Pearson VUE Professional Testing Centers during a defined window: September 8-28, 2026. For the full breakdown of deadlines and scheduling logistics, see BB/TM Exam Dates 2026: Testing Windows, Deadlines & Scheduling.

The exam itself is a one-day, computer-based test consisting of 280 single-best-answer multiple-choice questions, organized into six sections that combine written and practical material. "Practical" material includes antibody-identification panels, images, charts, graphs, tables, diagrams, formulas, and calculations - so candidates are expected to interpret visual and quantitative data, not just recall facts.

The 2026 schedule allocates six hours and 22 minutes of actual testing time. The full scheduled day, including the tutorial, survey, lunch, and other breaks, runs eight hours and 52 minutes. This is a long, demanding testing day, and pacing across six sections is itself a skill worth practicing - a topic we cover in depth in our How Hard Is the BB/TM Exam? Complete Difficulty Guide 2026 article.

How Passing Is Determined

BB/TM uses a criterion-referenced passing scaled score of 500, not a fixed raw percentage of correct answers. That means the number of questions you need to get right can vary slightly from year to year depending on exam form difficulty. For a full explanation of how this scoring model works, see BB/TM Passing Score 2026: Exactly What You Need to Pass.

According to ABPath's 2025 Annual Report (released in 2026), the overall pass rate that year was 90% (44/49 candidates), with first-time takers passing at 91% (39/43) and repeat takers at 83% (5/6). We unpack what these numbers mean for prospective candidates in BB/TM Pass Rate 2026: What the Data Shows.

The 15 Domains Behind the Acronym

The letters "BB/TM" compress an enormous amount of clinical territory. The 2026 examination blueprint organizes that territory into 15 domains, each with an official approximate weight across the combined written and practical sections. The weights total 100%.

Notice that "Clinical Practice" and "Hematopoietic Progenitor Cell Transplantation" together make up a quarter of the exam. This is a useful reminder that BB/TM is not just about serology and typing - it is about the clinical decision-making surrounding transfusion and cellular therapy, including patient-facing management scenarios.

For a domain-by-domain walkthrough with study strategies for each of the 15 areas, see our companion guide, BB/TM Exam Domains 2026: Complete Guide to All 15 Content Areas.

Who Can Sit for the BB/TM Exam

Eligibility requires holding AP/CP or CP primary certification from ABPath, or primary certification from another ABMS member board, plus completion of 12 months of ACGME-accredited Blood Banking/Transfusion Medicine fellowship training. Before certification is granted, candidates must also hold a qualifying medical degree, have their program training formally verified, and hold a full, unrestricted medical license. A detailed walkthrough of each requirement is available in BB/TM Requirements 2026: Eligibility, Prerequisites & How to Qualify.

After You Pass: Certificates and Continuing Certification

BB/TM certificates carry no fixed expiration date, but holding one remains contingent on staying current with ABPath's Continuing Certification program. The standard route requires 70 CME credits per two-year reporting cycle, with at least 80% of those credits related to the physician's scope of practice, plus at least two improvement-in-practice or quality-assurance activities per two-year cycle, alongside ongoing licensure and professionalism requirements.

ABPath also uses CertLink, a longitudinal assessment tool that assigns 10-15 questions per quarter. Diplomates must complete the assigned questions and maintain at least 60% correct cumulatively across the four-year assessment period. These maintenance obligations are entirely separate from the initial certification exam's passing score requirement - passing the exam once does not exempt a physician from ongoing assessment.

Who Hires BB/TM-Certified Physicians

Because BB/TM sits on top of general pathology certification, holders typically work as transfusion medicine directors, blood bank medical directors, or consulting pathologists for hospital systems, academic medical centers, and blood collection organizations. The domain weighting gives a clue as to daily responsibilities: heavy emphasis on Clinical Practice and HPC Transplantation reflects the reality that these physicians are frequently consulted on complex transfusion decisions, apheresis procedures, and stem cell collection and processing programs, not just laboratory oversight. If you're evaluating career paths tied to this credential, our overview of BB/TM Jobs and our analysis in BB/TM Salary Guide 2026: Complete Earnings Analysis and Is the BB/TM Certification Worth It? Complete ROI Analysis 2026 are useful next reads.

Turning the Name Into a Study Plan

Once you know what BB/TM stands for and how its domains are weighted, the natural next step is mapping preparation time against those weights rather than studying everything equally. A simple, BB/TM-specific way to sequence review is to front-load the heaviest domains early, when you have the most energy and time to revisit weak spots, and leave the lightest domains (Histocompatibility and Tissue Banking, Biovigilance) for short review sessions closer to the exam.

For a full walkthrough of this kind of sequencing, plus practice question strategy and pacing drills, see our BB/TM Study Guide 2026: How to Pass on Your First Attempt. You can also use our practice test platform to run timed, domain-weighted practice sessions that mirror the real exam's six-section structure, and revisit the main practice test site as you rotate through each domain listed above.

FAQs